YOLFTbeta
MEKICS Co Ltd

MEKICS Co Ltd

058110 · KQ · Healthcare / Healthcare Equipment & Supplies

1,376.00KRW+32.00 (+2.38%)

Price History

Full chart

Market Stats

Previous Close1,344.00
Open1,326.00
Day Range1,291.00 – 1,384.00
52-Week Range1,412.00 – 4,000.00
Volume46.33K
Market Cap23.35B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-1.80
50-Day Avg1,610.68
200-Day Avg1,998.21

About

MEKICS CO., Ltd develops and commercializes ventilators worldwide. It offers general-purpose ventilators, respiratory care devices, patient monitoring systems, pulse oximeter, central monitoring system, and high flow nasal therapy products. The company also distributes CPAP solutions that care sleep apnea syndrome and snoring. MEKICS CO., Ltd was founded in 1998 and is headquartered in Paju, South Korea.

Company Details

  • SectorHealthcare
  • IndustryHealthcare Equipment & Supplies
  • CEOMr. Jong-Cheol Kim
  • Employees0
  • Headquarters21, Sangjiseok-gil, Paju-Si, South Korea, 10911, Korea
  • Websitehttp://mek-ics.com

Leadership

  • Mr. Jong-Cheol KimCEO · b. 1965
  • Mr. Han-Bae LeeManaging Director · b. 1959
  • Mr. Woo-Yeong JungDirector · b. 1971
  • Mr. Suk-Sun ChoiManaging Director · b. 1959

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue9.00B7.92B8.60B8.73B12.86B68.05B49.30B28.75B13.26B11.37B11.29B
Growth (%)--12.02%+8.61%+1.45%+47.39%+429.04%-27.56%-41.67%-53.88%-14.27%-0.71%
Cost of Revenue4.85B4.55B5.04B5.33B7.33B29.20B24.58B15.29B15.13B11.55B5.13B
Gross Profit4.15B3.37B3.56B3.40B5.53B38.85B24.71B13.46B-1.87B-185.42M6.16B
Gross Margin46.09%42.54%41.38%38.92%43.01%57.09%50.13%46.81%-14.11%-1.63%54.53%
Operating Expense1.70B4.80B4.58B5.22B5.94B8.51B14.08B15.23B12.23B9.31B8.94B
Operating Income2.45B-1.43B-1.02B-1.83B-410.66M30.35B10.63B-1.77B-14.11B-9.49B-2.79B
Operating Margin27.19%-18.03%-11.89%-20.93%-3.19%44.59%21.57%-6.15%-106.37%-83.49%-24.69%
EBITDA-------222.55M-13.62B-8.04B-748.00M
EBITDA Margin-------0.77%-102.74%-70.70%-6.63%
Net Income2.60B-1.78B-1.95B-2.71B-1.43B24.16B9.48B-2.67B-16.12B-10.17B-2.54B
Net Income Margin28.85%-22.52%-22.63%-31.03%-11.13%35.50%19.23%-9.30%-121.57%-89.42%-22.50%
R&D1.26B1.26B1.07B1.08B-1.99B3.15B3.32B3.19B2.65B1.84B
R&D as % of Total Revenue14.01%15.90%12.46%12.42%-2.92%6.39%11.53%24.09%23.28%16.34%
Interest Expense00000211.46M880.13M1.01B666.73M699.27M606.15M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.31%1.79%3.52%5.03%6.15%5.37%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets21.69B25.03B22.74B24.44B24.85B70.59B96.74B86.76B68.68B59.45B56.22B
Total Liabilities11.44B15.19B14.87B19.36B20.81B31.95B25.74B19.15B18.87B20.27B19.59B
Total Equity10.25B9.84B7.87B5.08B4.04B38.63B71.00B67.61B49.68B39.18B36.64B
Cash2.91B5.38B3.55B420120-52028.94B5.15B5.46B2.62B3.39B
Total Debt---10.85B11.11B14.22B-----
Net Debt----15.92B12.12B-8.43B9.31B13.79B12.53B

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-95.96M-2.23B-944.42M-1.62B-1.06B3.45B7.11B5.74B-3.39B-3.48B-2.46B
Investing Cash Flow--1.87B-257.27M-261.78M-1.78B-128.52M-10.00B-6.16B-27.21B3.77B-752.23M-
Financing Cash Flow-2.53B4.96B-608.78M895.64M770.83M8.67B25.23B-2.30B-68.15M1.48B-
Capital Expenditure03.88B324.77M343.89M206.51M163.81M9.35B3.40B4.96B4.80B3.94B96.33M
Free Cash Flow-------5.92B2.47B782.14M-8.19B-7.42B-2.56B
Dividends Paid14.56M93.17K93.17K0---1.01B1.30B470.06M0-
FCF to OCF-------171.61%34.77%13.62%241.37%213.23%103.91%
Dividend Paid to FCF-------40.68%166.29%-5.74%0.00%-

Earnings

Report DateMay 21, 2016Aug 26, 2016Nov 18, 2016Feb 9, 2017May 16, 2017Aug 16, 2017Nov 14, 2017Jan 29, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 20, 2019May 15, 2019Aug 13, 2019Nov 13, 2019Feb 10, 2020May 14, 2020Jul 27, 2020Nov 11, 2020Jan 26, 2021May 13, 2021Aug 1, 2021Nov 15, 2021Feb 4, 2022May 18, 2022Aug 16, 2022Nov 14, 2022Mar 1, 2023May 15, 2023Aug 16, 2023Nov 15, 2023May 14, 2024Aug 14, 2024Nov 14, 2024Feb 26, 2025May 21, 2025Aug 15, 2025Nov 19, 2025Mar 17, 2026May 14, 2026Aug 19, 2026
EPS Estimate-------------------6335.502978.50--------------------
EPS Actual-50.78-52.75-53.24-5.0715.51-18.80-82.00-120.72-51.34-49.45-48.75-96.152.08-0.07-39.86-91.4446.97812.03716.86342.0325.50436.00126.00-1.0066.6398.00-95.35-239.49-146.49-393.17-134.51-121.65-109.23-152.52-272.49-70.08-109.28-10.5326.0238.0114.88
Surprise--------------------94.60%-99.14%--------------------
TimingAfter-hoursAfter-hoursAfter-hours--After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hours-After-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-market--Pre-market--------------

Key Statistics & Ratios

Market Cap23.35B
Enterprise Value31.75B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.68
Price / Book0.62
Revenue (TTM)33.24B
Gross Profit (TTM)24.46B
EBITDA1.87B
Profit Margin3.21%
Operating Margin-2.75%
Return on Equity-2188.55%
Return on Assets-0.58%
Shares Outstanding5.36M
Shares Float11.54M
Beta-1.80
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
30.00Dec 27, 2023
20221×
30.00Dec 28, 2022
20211×
83.00Dec 29, 2021
20201×
70.05Dec 29, 2020

Stock Splits

  • Feb 26, 20212:1
  • Jan 14, 20211587:1544